每周分子 | Molecule of the Week
每周分子:Zoliflodacin
Molecule of the Week: Zoliflodacin
2014年,美国马萨诸塞州威瑟姆市阿斯利康实验室的Gregory S. Basarab及其联合发明人提交了名为“治疗细菌感染的化合物和及其制备方法(Compounds and Methods for Treating Bacterial Infections)”的美国专利申请。本发明的化合物为spiro(isoxazolo[4,5-g][oxazino[4,3-a]quinolinepyrimidine)trione的衍生物。在这些衍生物中,有一种化合物AZD0914,后来被称为zoliflodacin。
本申请的模糊标题掩盖了其特定目的:寻找潜在药物对抗多药耐药性细菌。在本申请的技术背景部分,发明人指出:“根据美国传染病学会报道,美国每年死于耐甲氧西林金黄色葡萄球菌(MRSA)的病人比死于肺气肿、艾滋病毒/艾滋病、帕金森氏症和谋杀的人数加起来还要多。” 他们接着列举了几个当时已经产生抗药性的细菌的例子。
在列出的细菌中有淋病奈瑟菌——一种导致性传播疾病淋病的革兰氏阴性菌。Zoliflodacin是一种DNA旋回酶(细菌拓扑异构酶的一个亚类)抑制剂,对治疗淋病有特别的疗效。今年,John P. Mueller和来自Entasis Therapeutics (AstraZeneca Waltham的子公司)的同事们以及抗菌药物开发专家(Nyack, NY)们共同发表了一份关于zoliflodacin的开发、活性研究、作用模式以及一期和二期临床试验的完整报告。
作者们还宣布了今年将开始对1000名受试者进行临床三期试验。该试验预计将于2021年完成。
Zoliflodacin信息速览
Zoliflodacin危害信息
【关于每周分子】
In 2014, Gregory S. Basarab and co-inventors at the AstraZeneca lab in Waltham, MA, filed a US patent application titled “Compounds and Methods for Treating Bacterial Infections”. The compounds of the invention were derivatives of spiro(isoxazolo[4,5-g][oxazino[4,3-a]quinolinepyrimidine)trione. Among the derivatives, there was a compound, AZD0914, that came to be known as zoliflodacin.
The vague title of the application belies its specific purpose: to identify potential drugs to combat multidrug-resistant infectious bacteria. In the background section of the application, the inventors state, “[A]ccording to the Infectious Disease Society of America, methicillin-resistant Staphylococcus aureus (MRSA) kills more Americans every year than emphysema, HIV/AIDS, Parkinson's disease, and homicide combined.” They go on to list several examples of bacteria that had become drug-resistant at the time.
Among the listed bacteria is Neisseria gonorrhoeae, the Gram-negative species that is responsible for the sexually transmitted disease gonorrhea. Zoliflodacin, an inhibitor of DNA gyrase (a subclass of bacterial topoisomerase) is particularly effective for treating this disease. This year, John P. Mueller and co-workers at Entasis Therapeutics (the spinoff from AstraZeneca Waltham) and Antimicrobial Development Specialists (Nyack, NY) published a full report of the development, activity, mode of action, and Phase 1 and 2 clinical trials of zoliflodacin.
The authors also announced the beginning of a Phase 3 trial on ≈1000 subjects this year. The trial is expected to be completed in 2021.
Zoliflodacin azide fast facts
Zoliflodacin hazard information
About Molecule of the Week
Copyright © 2020 American Chemical Society
每周分子Molecule of the Week:Azidoazide azide
每周分子Molecule of the Week:D-葡萄糖胺
每周分子Molecule of the Week:六氟-2-丁烯
每周分子Molecule of the Week:EIDD-2801
每周分子Molecule of the Week:铱络合物阳离子八聚体
每周分子Molecule of the Week:去甲肾上腺素
每周分子Molecule of the Week:镍钐氧化物
每周分子Molecule of the Week:二亚乙基三胺
每周分子 | Molecule of the Week:过氧乙酰硝酸酯
每周分子Molecule of the Week:比马前列素
每周分子 | Molecule of the Week:二氧化钒
每周分子 | Molecule of the Week: 比马前列素
每周分子 | Molecule of the Week:2-氰基丙烯酸乙酯
每周分子 | Molecule of the Week:丁酸庚酯
每周分子 | Molecule of the Week:丙烯酰胺
每周分子 | Molecule of the Week: 氯酸钾
每周分子 | Molecule of the Week:12-羟基硬脂酸锂
每周分子 | Molecule of the Week:二烷基二硫代磷酸锌
每周分子 | Molecule of the Week:熊去氧胆酸
每周分子 | Molecule of the Week:糠醛
每周分子 | Molecule of the Week:环氧乙烷
每周分子 | Molecule of the Week:硝酸甘油
每周分子 | Molecule of the Week:阿斯巴甜
每周分子 | Molecule of the Week: 反式肉桂醛
每周分子 | Molecule of the Week:Trivertal
每周分子 | Molecule of the Week:甲醛次硫酸氢鈉
每周分子 | Molecule of the Week:麦克风
每周分子 | Molecule of the Week:缩水甘油
每周分子 | Molecule of the Week:二恶烷四酮
每周分子 | Molecule of the Week:呋喃妥因
每周分子 | Molecule of the Week:并四苯
每周分子 | Molecule of the Week: 两性霉素B
每周分子 | Molecule of the Week:肌苷
每周分子 | Molecule of the Week:D-葡萄糖酸
每周分子 | Molecule of the Week:糖精
每周分子 | Molecule of the Week:靛玉红
每周分子 | Molecule of the Week: 二氧化銥
每周分子 | Molecule of the Week: 硼烯
每周分子 | Molecule of the Week:苦杏仁苷及其衍生物Laetrile
每周分子 | Molecule of the Week:氦化氢
每周分子 | Molecule of the Week: 白杨素和哈尔满
每周分子 | Molecule of the Week:阿维巴坦钠
每周分子 | Molecule of the Week:氟哌啶醇
每周分子 | Molecule of the Week:2-己基肉桂醛
每周分子 | Molecule of the Week:大蒜烯
每周分子 | Molecule of the Week:替莫唑胺
每周分子 | Molecule of the Week:二氢左旋葡萄糖酮
每周分子 | Molecule of the Week:甲苯
每周分子 | Molecule of the Week:乙酸乙酯
每周分子 | Molecule of the Week:二氯甲烷
每周分子 | Molecule of the Week:拉罗替尼
每周分子 | Molecule of the Week:叶绿素
每周分子 | Molecule of the Week: 苯乙腈葡糖苷
每周分子Molecule of the Week:红花菜豆酸
每周分子Molecule of the Week:盐酸氮卓斯汀
每周分子Molecule of the Week:(+)-乙酸龙脑酯
每周分子Molecule of the Week:阿波霉素δ2
每周分子Molecule of the Week:L-半胱氨酸
每周分子Molecule of the Week: 莫西菌素
每周分子Molecule of the Week:L-丙氨酸和L-丝氨酸
每周分子Molecule of the Week: N,N-二甲基色胺
每周分子Molecule of the Week:2,4-二硫杂戊烷
每周分子 Molecule of the Week: 尼古丁
每周分子 Molecule of the Week:透明质酸
每周分子Molecule of the Week:羟苯甲酮和桂皮酸盐
每周分子Molecule of the Week: 水仙环素
每周分子Molecule of the Week:月桂酸和肉豆蔻酸
每周分子Molecule of the Week:Cucurbitacins
每周分子Molecule of the Week:Fluralaner
由于近期微信更改了订阅号的推送规则,很多朋友不能快速找到我们,其实我们每天都在推送!您可以将ACS美国化学会设置为星标🌟,就能在微信订阅号中快速找到我们,查看每天订阅。
点击“阅读原文”
你“在看”我吗?